An inhibitor of 17β-HSD3
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

TC HSD 21

Item No. 29730

Technical Information
Formal Name
5-[(3-bromo-4-hydroxyphenyl)methylene]-3-(4-methoxyphenyl)-2-thioxo-4-thiazolidinone
CAS Number
330203-01-5
Synonyms
  • TC Hydroxysteroid Dehydrogenase 21
Molecular Formula
C17H12BrNO3S2
Formula Weight
Purity
≥98%
Formulation
A solid
SMILES
OC1=CC=C(/C=C2SC(N(C3=CC=C(OC)C=C3)C\2=O)=S)C=C1Br
InChi Code
InChI=1S/C17H12BrNO3S2/c1-22-12-5-3-11(4-6-12)19-16(21)15(24-17(19)23)9-10-2-7-14(20)13(18)8-10/h2-9,20H,1H3/b15-9-
InChi Key
HEFKAUYVLSGPGC-DHDCSXOGSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Product Description

    TC HSD 21 is an inhibitor of 17β-hydroxysteroid dehydrogenase type 3 (17β-HSD3; IC50 = 14 nM in HeLa cells expressing the recombinant human enzyme).1 It is selective for 17β-HSD3 over 17β-HSD1, 17β-HSD2, estrogen receptor α (ERα), the androgen receptor, and the glucocorticoid receptor.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Harada, K., Kubo, H., Tanaka, A., et alIdentification of oxazolidinediones and thiazolidinediones as potent 17β-hydroxysteroid dehydrogenase type 3 inhibitors. Bioorg. Med. Chem. Lett. 22(1), 504-507 (2012).